Academic Pediatrics, ISSN 1876-2859, 2012, Volume 12, Issue 3, pp. e5 - e5
Journal Article
Academic Pediatrics, ISSN 1876-2859, 2012, Volume 12, Issue 3, pp. e5 - e6
Journal Article
Pediatrics, ISSN 0031-4005, 03/2009, Volume 123, Issue 3, pp. 1066 - 1072
OBJECTIVE. Our goal was to report our institutional experience with recombinant factor VIIa for the treatment and/or prevention of bleeding in nonhemophiliac...
Recombinant factor viia | Pediatrics | Transfusion | Thromboembolism | Bleeding | bleeding | thromboembolism | HEMORRHAGE | transfusion | recombinant factor VIIa | ACTIVATED FACTOR-VII | RFVIIA | CHILDREN | THERAPY | CARDIAC-SURGERY | pediatrics | CONGENITAL HEART-DISEASE | DOUBLE-BLIND | COAGULATION | TRAUMA PATIENTS | Humans | Prothrombin Time | Child, Preschool | Hemorrhage - mortality | Hospitals, Pediatric | Infant | Male | Drug Approval | Disseminated Intravascular Coagulation - mortality | Factor VIIa - adverse effects | Recombinant Proteins - adverse effects | Postoperative Hemorrhage - blood | Dose-Response Relationship, Drug | Factor VIIa - administration & dosage | Postoperative Hemorrhage - drug therapy | Female | Child | Postoperative Hemorrhage - mortality | Blood Loss, Surgical - prevention & control | Wounds and Injuries - blood | Disseminated Intravascular Coagulation - drug therapy | Wounds and Injuries - complications | Survival Rate | Hemorrhage - blood | Disseminated Intravascular Coagulation - blood | Recombinant Proteins - administration & dosage | Wounds and Injuries - mortality | Hemorrhage - drug therapy | Partial Thromboplastin Time | Adolescent | Premedication | Usage | Care and treatment | Prognosis | Mortality | Patient outcomes | Blood coagulation factors | Alabama | Hemorrhage | Diseases | Prevention | Control | Children | Health aspects | Proteins | Blood products | Medical treatment | Cells | Children & youth
Recombinant factor viia | Pediatrics | Transfusion | Thromboembolism | Bleeding | bleeding | thromboembolism | HEMORRHAGE | transfusion | recombinant factor VIIa | ACTIVATED FACTOR-VII | RFVIIA | CHILDREN | THERAPY | CARDIAC-SURGERY | pediatrics | CONGENITAL HEART-DISEASE | DOUBLE-BLIND | COAGULATION | TRAUMA PATIENTS | Humans | Prothrombin Time | Child, Preschool | Hemorrhage - mortality | Hospitals, Pediatric | Infant | Male | Drug Approval | Disseminated Intravascular Coagulation - mortality | Factor VIIa - adverse effects | Recombinant Proteins - adverse effects | Postoperative Hemorrhage - blood | Dose-Response Relationship, Drug | Factor VIIa - administration & dosage | Postoperative Hemorrhage - drug therapy | Female | Child | Postoperative Hemorrhage - mortality | Blood Loss, Surgical - prevention & control | Wounds and Injuries - blood | Disseminated Intravascular Coagulation - drug therapy | Wounds and Injuries - complications | Survival Rate | Hemorrhage - blood | Disseminated Intravascular Coagulation - blood | Recombinant Proteins - administration & dosage | Wounds and Injuries - mortality | Hemorrhage - drug therapy | Partial Thromboplastin Time | Adolescent | Premedication | Usage | Care and treatment | Prognosis | Mortality | Patient outcomes | Blood coagulation factors | Alabama | Hemorrhage | Diseases | Prevention | Control | Children | Health aspects | Proteins | Blood products | Medical treatment | Cells | Children & youth
Journal Article
Pediatric Critical Care Medicine, ISSN 1529-7535, 2007, Volume 8, Issue 2, pp. 161 - 164
Objective: To report five cases of errors in the placement of oral/nasal enteral tubes in a pediatric intensive care unit, and to review literature on...
Critical care | Pneumothorax | Enteral tube | Pediatric | Morbidity | NASOENTERAL FEEDING TUBES | enteral tube | critical care | CONFIRMATION | CRITICALLY-ILL | CAPNOGRAPHY | pediatric | pneumothorax | CHILDREN | PEDIATRICS | PATIENT | morbidity | CRITICAL CARE MEDICINE | Humans | Nose | Adolescent | Female | Infant | Intensive Care Units, Pediatric | Male | Intubation, Gastrointestinal - adverse effects | Enteral Nutrition - instrumentation | Child | Medical Errors - prevention & control
Critical care | Pneumothorax | Enteral tube | Pediatric | Morbidity | NASOENTERAL FEEDING TUBES | enteral tube | critical care | CONFIRMATION | CRITICALLY-ILL | CAPNOGRAPHY | pediatric | pneumothorax | CHILDREN | PEDIATRICS | PATIENT | morbidity | CRITICAL CARE MEDICINE | Humans | Nose | Adolescent | Female | Infant | Intensive Care Units, Pediatric | Male | Intubation, Gastrointestinal - adverse effects | Enteral Nutrition - instrumentation | Child | Medical Errors - prevention & control
Journal Article
Cytokine and Growth Factor Reviews, ISSN 1359-6101, 2002, Volume 13, Issue 3, pp. 277 - 287
Metallo-proteinases are implicated in many processes involved in tissue remodeling, cell motility, morphogenesis, and cell and organ growth and...
Metzincin | Matrix metallo-proteinase | Adamalysins | Cytokine | Growth factor | cytokine | CONVERTING-ENZYME TACE | FACTOR-BINDING PROTEIN-3 | TUMOR PROGRESSION | BIOCHEMISTRY & MOLECULAR BIOLOGY | CELL-SURFACE | NECROSIS-FACTOR-ALPHA | CELL BIOLOGY | growth factor | MATRIX METALLOPROTEINASES | metzincin | LUNG BRANCHING MORPHOGENESIS | HUMAN-PREGNANCY SERUM | A PAPP-A | adamalysins | matrix metallo-proteinase | PLASMA-PROTEIN | ADAM17 Protein | Cytokines - metabolism | Humans | Epidermal Growth Factor - metabolism | Metalloendopeptidases - metabolism | ADAM Proteins | Insulin-Like Growth Factor II - metabolism | Animals | Metalloendopeptidases - pharmacology | Models, Biological | Transforming Growth Factor alpha - metabolism | Transforming Growth Factor beta - metabolism | Insulin-Like Growth Factor I - metabolism | Growth Substances - metabolism
Metzincin | Matrix metallo-proteinase | Adamalysins | Cytokine | Growth factor | cytokine | CONVERTING-ENZYME TACE | FACTOR-BINDING PROTEIN-3 | TUMOR PROGRESSION | BIOCHEMISTRY & MOLECULAR BIOLOGY | CELL-SURFACE | NECROSIS-FACTOR-ALPHA | CELL BIOLOGY | growth factor | MATRIX METALLOPROTEINASES | metzincin | LUNG BRANCHING MORPHOGENESIS | HUMAN-PREGNANCY SERUM | A PAPP-A | adamalysins | matrix metallo-proteinase | PLASMA-PROTEIN | ADAM17 Protein | Cytokines - metabolism | Humans | Epidermal Growth Factor - metabolism | Metalloendopeptidases - metabolism | ADAM Proteins | Insulin-Like Growth Factor II - metabolism | Animals | Metalloendopeptidases - pharmacology | Models, Biological | Transforming Growth Factor alpha - metabolism | Transforming Growth Factor beta - metabolism | Insulin-Like Growth Factor I - metabolism | Growth Substances - metabolism
Journal Article
Academic Pediatrics, ISSN 1876-2859, 2015, Volume 15, Issue 4, pp. 380 - 385
Abstract Objective Communication and professionalism are often challenging to teach, and the impact of the use of a given approach is not known. We undertook...
Pediatrics | Neonatal and Perinatal Medicine | evaluation | graduate medical education | professionalism | fellowship training | competency | communication | pediatric | HIDDEN CURRICULUM | FACULTY | STYLES | PEDIATRICS | PERCEPTIONS | Attitude of Health Personnel | United States | Humans | Professionalism - education | Critical Care | Curriculum | Surveys and Questionnaires | Students, Medical | Pediatrics - education | Communication
Pediatrics | Neonatal and Perinatal Medicine | evaluation | graduate medical education | professionalism | fellowship training | competency | communication | pediatric | HIDDEN CURRICULUM | FACULTY | STYLES | PEDIATRICS | PERCEPTIONS | Attitude of Health Personnel | United States | Humans | Professionalism - education | Critical Care | Curriculum | Surveys and Questionnaires | Students, Medical | Pediatrics - education | Communication
Journal Article
AJP - Lung Cellular and Molecular Physiology, ISSN 1040-0605, 07/2002, Volume 283, Issue 1, pp. 1 - L11
1 Â Department of Pediatrics, University of Alabama at Birmingham and Children's Hospital of Alabama, Birmingham, Alabama 35233; and 2 Â Department of...
Acute respiratory distress syndrome | Bronchopulmonary dysplasia | Cytokines | Emphysema | Lung fibrosis | CONVERTING-ENZYME TACE | BRONCHOALVEOLAR LAVAGE FLUID | PHYSIOLOGY | FACTOR-BINDING PROTEIN-3 | ACUTE LUNG INJURY | DIFFUSE ALVEOLAR DAMAGE | NECROSIS-FACTOR-ALPHA | bronchopulmonary dysplasia | lung fibrosis | emphysema | RESPIRATORY-DISTRESS-SYNDROME | MATRIX METALLOPROTEINASES | RESPIRATORY SYSTEM | acute respiratory distress syndrome | TISSUE INHIBITOR | cytokines | AIRWAY SMOOTH-MUSCLE | Metalloendopeptidases - metabolism | Pulmonary Fibrosis - metabolism | Humans | Pulmonary Fibrosis - physiopathology | Growth Substances - metabolism
Acute respiratory distress syndrome | Bronchopulmonary dysplasia | Cytokines | Emphysema | Lung fibrosis | CONVERTING-ENZYME TACE | BRONCHOALVEOLAR LAVAGE FLUID | PHYSIOLOGY | FACTOR-BINDING PROTEIN-3 | ACUTE LUNG INJURY | DIFFUSE ALVEOLAR DAMAGE | NECROSIS-FACTOR-ALPHA | bronchopulmonary dysplasia | lung fibrosis | emphysema | RESPIRATORY-DISTRESS-SYNDROME | MATRIX METALLOPROTEINASES | RESPIRATORY SYSTEM | acute respiratory distress syndrome | TISSUE INHIBITOR | cytokines | AIRWAY SMOOTH-MUSCLE | Metalloendopeptidases - metabolism | Pulmonary Fibrosis - metabolism | Humans | Pulmonary Fibrosis - physiopathology | Growth Substances - metabolism
Journal Article
Pediatric Critical Care Medicine, ISSN 1529-7535, 05/2009, Volume 10, Issue 3, pp. 323 - 327
Objective: An increase in community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections has been reported in the literature. Most...
Necrotizing pneumonia | Vancomycin | Pediatric intensive care unit | Severe sepsis | Methicillin-resistant Staphylococcus aureus | MORTALITY | severe sepsis | methicillin-resistant Staphylococcus aureus | CLINDAMYCIN TREATMENT | DAPTOMYCIN | IN-VITRO | BACTEREMIA | PREDICTORS | pediatric intensive care unit | necrotizing pneumonia | vancomycin | PEDIATRICS | ENDOCARDITIS | INHIBITORY CONCENTRATION | TREATMENT FAILURE | CRITICAL CARE MEDICINE | Staphylococcal Infections - drug therapy | Humans | Child, Preschool | Drug Resistance, Bacterial | Medical Audit | Male | Intensive Care Units, Pediatric - statistics & numerical data | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Staphylococcal Infections - mortality | Vancomycin - therapeutic use | Adolescent | Alabama - epidemiology | Female | Retrospective Studies | Staphylococcal Infections - microbiology | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Child
Necrotizing pneumonia | Vancomycin | Pediatric intensive care unit | Severe sepsis | Methicillin-resistant Staphylococcus aureus | MORTALITY | severe sepsis | methicillin-resistant Staphylococcus aureus | CLINDAMYCIN TREATMENT | DAPTOMYCIN | IN-VITRO | BACTEREMIA | PREDICTORS | pediatric intensive care unit | necrotizing pneumonia | vancomycin | PEDIATRICS | ENDOCARDITIS | INHIBITORY CONCENTRATION | TREATMENT FAILURE | CRITICAL CARE MEDICINE | Staphylococcal Infections - drug therapy | Humans | Child, Preschool | Drug Resistance, Bacterial | Medical Audit | Male | Intensive Care Units, Pediatric - statistics & numerical data | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Staphylococcal Infections - mortality | Vancomycin - therapeutic use | Adolescent | Alabama - epidemiology | Female | Retrospective Studies | Staphylococcal Infections - microbiology | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Child
Journal Article
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, ISSN 1529-7535, 2013, Volume 14, Issue 5, pp. 454 - 461
Objectives: To describe the teaching and evaluation modalities used by pediatric critical care medicine training programs in the areas of professionalism and...
graduate medical education | professionalism | EMERGENCY-MEDICINE | CURRICULUM | fellowship training | competency | GAP ANALYSIS | EDUCATION | COMPETENCE | pediatric | evaluation | RESIDENTS | MINI-EVALUATION EXERCISE | INTERPERSONAL SKILLS | STANDARDIZED PATIENTS | FAMILY CONFERENCE | PEDIATRICS | communication | CRITICAL CARE MEDICINE | Curriculum - standards | Fellowships and Scholarships | Faculty, Medical | Cross-Sectional Studies | Humans | Critical Care | Professional Role | Pediatrics - education | Program Evaluation | Communication | Education, Medical, Graduate - methods
graduate medical education | professionalism | EMERGENCY-MEDICINE | CURRICULUM | fellowship training | competency | GAP ANALYSIS | EDUCATION | COMPETENCE | pediatric | evaluation | RESIDENTS | MINI-EVALUATION EXERCISE | INTERPERSONAL SKILLS | STANDARDIZED PATIENTS | FAMILY CONFERENCE | PEDIATRICS | communication | CRITICAL CARE MEDICINE | Curriculum - standards | Fellowships and Scholarships | Faculty, Medical | Cross-Sectional Studies | Humans | Critical Care | Professional Role | Pediatrics - education | Program Evaluation | Communication | Education, Medical, Graduate - methods
Journal Article
Pediatric Research, ISSN 0031-3998, 07/2005, Volume 58, Issue 1, pp. 89 - 93
IGF-I and IGF-II are ubiquitously expressed growth factors that have profound effects on the growth and differentiation of many cell types and tissues,...
Insulin-Like Growth Factor II - cerebrospinal fluid | Insulin-Like Growth Factor I - cerebrospinal fluid | Age Factors | Enzyme-Linked Immunosorbent Assay | Humans | Gene Expression Regulation | Child, Preschool | Infant | Male | Insulin-Like Growth Factor Binding Protein 3 - cerebrospinal fluid | Chemistry, Clinical - methods | Insulin-Like Growth Factor Binding Protein 1 - cerebrospinal fluid | Nervous System - growth & development | Adolescent | Sex Factors | Female | Neurons - metabolism | Child | Infant, Newborn
Insulin-Like Growth Factor II - cerebrospinal fluid | Insulin-Like Growth Factor I - cerebrospinal fluid | Age Factors | Enzyme-Linked Immunosorbent Assay | Humans | Gene Expression Regulation | Child, Preschool | Infant | Male | Insulin-Like Growth Factor Binding Protein 3 - cerebrospinal fluid | Chemistry, Clinical - methods | Insulin-Like Growth Factor Binding Protein 1 - cerebrospinal fluid | Nervous System - growth & development | Adolescent | Sex Factors | Female | Neurons - metabolism | Child | Infant, Newborn
Journal Article
American Journal of Physiology, ISSN 1040-0605, 04/2003, Volume 28, Issue 4, p. L557
 Matrix metalloproteinases (MMPs) are a large family (>20) of cation-dependent proteinases believed to be important modulators of normal human lung...
Proteins | Pediatrics | Matrix | Lungs | Disease
Proteins | Pediatrics | Matrix | Lungs | Disease
Journal Article
Journal of Critical Care, ISSN 0883-9441, 2008, Volume 23, Issue 3, pp. 416 - 421
Abstract Purpose The aim of this study was to assess gastric pH in critically ill pediatric patients receiving intravenous stress ulcer medication. Materials...
Critical Care | Gastric pH | Histamine 2 receptor antagonists | Children | Stress ulcer prophylaxis | Proton pump inhibitor | ACID SUPPRESSION | OMEPRAZOLE | STRESS-ULCER PROPHYLAXIS | RISK | PHARMACODYNAMICS | histamine 2 receptor antagonists | CRITICALLY-ILL CHILDREN | proton pump inhibitors | stress ulcer prophylaxis | THERAPY | PHARMACOKINETICS | children | gastric pH | RANITIDINE | CRITICAL CARE MEDICINE | Injections, Intravenous | Prospective Studies | Humans | Child, Preschool | Peptic Ulcer - prevention & control | Infant | Intensive Care Units, Pediatric | Male | Proton Pump Inhibitors - therapeutic use | Gastric Juice - chemistry | Histamine H2 Antagonists - therapeutic use | Respiration, Artificial | Proton Pump Inhibitors - administration & dosage | Adolescent | Female | Child | Infant, Newborn | Peptic Ulcer - etiology | Stress, Psychological - complications | Hydrogen-Ion Concentration | Ranitidine - therapeutic use | Renal Dialysis | Pediatrics | Histamine | Proton pump inhibitors | Comparative analysis | Hydrogen-ion concentration | Health aspects
Critical Care | Gastric pH | Histamine 2 receptor antagonists | Children | Stress ulcer prophylaxis | Proton pump inhibitor | ACID SUPPRESSION | OMEPRAZOLE | STRESS-ULCER PROPHYLAXIS | RISK | PHARMACODYNAMICS | histamine 2 receptor antagonists | CRITICALLY-ILL CHILDREN | proton pump inhibitors | stress ulcer prophylaxis | THERAPY | PHARMACOKINETICS | children | gastric pH | RANITIDINE | CRITICAL CARE MEDICINE | Injections, Intravenous | Prospective Studies | Humans | Child, Preschool | Peptic Ulcer - prevention & control | Infant | Intensive Care Units, Pediatric | Male | Proton Pump Inhibitors - therapeutic use | Gastric Juice - chemistry | Histamine H2 Antagonists - therapeutic use | Respiration, Artificial | Proton Pump Inhibitors - administration & dosage | Adolescent | Female | Child | Infant, Newborn | Peptic Ulcer - etiology | Stress, Psychological - complications | Hydrogen-Ion Concentration | Ranitidine - therapeutic use | Renal Dialysis | Pediatrics | Histamine | Proton pump inhibitors | Comparative analysis | Hydrogen-ion concentration | Health aspects
Journal Article
American Journal of Physiology - Lung Cellular and Molecular Physiology, ISSN 1040-0605, 04/2003, Volume 284, Issue 4, pp. 557 - 565
Matrix metalloproteinases (MMPs) are a large family (>20) of cation-dependent proteinases believed to be important modulators of normal human lung development...
Bronchoalveolar lavage | Extracellular matrix | PHYSIOLOGY | RESPIRATORY-DISTRESS | OBSTRUCTIVE PULMONARY-DISEASE | EPITHELIAL-CELLS | RESPIRATORY SYSTEM | GELATINASE-B | MATRIX-METALLOPROTEINASE-9 | TISSUE INHIBITOR | ALVEOLAR MACROPHAGES | GROWTH-FACTOR | bronchoalveolar lavage | UP-REGULATION | extracellular matrix | ACUTE ASTHMA | Bronchoalveolar Lavage Fluid | Matrix Metalloproteinase 2 - metabolism | Humans | Child, Preschool | Infant | Male | Lung Diseases - therapy | Respiratory Insufficiency - therapy | Respiration, Artificial | Lung - enzymology | Extracellular Matrix - enzymology | Matrix Metalloproteinase 9 - metabolism | Respiratory Insufficiency - enzymology | Matrix Metalloproteinase 7 - metabolism | Matrix Metalloproteinase 8 - metabolism | Adolescent | Adult | Female | Matrix Metalloproteinases - metabolism | Child | Lung Diseases - enzymology
Bronchoalveolar lavage | Extracellular matrix | PHYSIOLOGY | RESPIRATORY-DISTRESS | OBSTRUCTIVE PULMONARY-DISEASE | EPITHELIAL-CELLS | RESPIRATORY SYSTEM | GELATINASE-B | MATRIX-METALLOPROTEINASE-9 | TISSUE INHIBITOR | ALVEOLAR MACROPHAGES | GROWTH-FACTOR | bronchoalveolar lavage | UP-REGULATION | extracellular matrix | ACUTE ASTHMA | Bronchoalveolar Lavage Fluid | Matrix Metalloproteinase 2 - metabolism | Humans | Child, Preschool | Infant | Male | Lung Diseases - therapy | Respiratory Insufficiency - therapy | Respiration, Artificial | Lung - enzymology | Extracellular Matrix - enzymology | Matrix Metalloproteinase 9 - metabolism | Respiratory Insufficiency - enzymology | Matrix Metalloproteinase 7 - metabolism | Matrix Metalloproteinase 8 - metabolism | Adolescent | Adult | Female | Matrix Metalloproteinases - metabolism | Child | Lung Diseases - enzymology
Journal Article
14.
Full Text
The Accreditation Council for Graduate Medical Education proposed work hour regulations
Pediatric Critical Care Medicine, ISSN 1529-7535, 01/2011, Volume 12, Issue 1, pp. 120 - 121
Journal Article
Journal of Neurosurgery, ISSN 0022-3085, 05/2004, Volume 100, Issue 5, pp. 454 - 459
Object. The authors sought to compare cerebral perfusion pressure (CPP)- with intracranial pressure (ICP)-targeted therapy in children with severe traumatic...
Glasgow Coma Scale | Glasgow Outcome Scale | Intracranial pressure | Cerebral edema | Cerebral perfusion pressure | Trauma | Brain injury | trauma | SURGERY | MANAGEMENT | cerebral edema | PRACTICAL SCALE | BLOOD-FLOW | COMA DATA-BANK | ADULT | CLINICAL NEUROLOGY | brain injury | intracranial pressure | SEVERE HEAD-INJURY | HYPOTENSION | HYPERTENSION | INSULTS | cerebral perfusion pressure | Prospective Studies | Humans | Child, Preschool | Brain Injuries - complications | Infant | Male | Treatment Outcome | Cerebrovascular Circulation | Combined Modality Therapy | Intracranial Pressure - physiology | Likelihood Functions | Pilot Projects | Adolescent | Female | Child | Intracranial Hypertension - etiology | Intracranial Hypertension - physiopathology | Intracranial Hypertension - therapy
Glasgow Coma Scale | Glasgow Outcome Scale | Intracranial pressure | Cerebral edema | Cerebral perfusion pressure | Trauma | Brain injury | trauma | SURGERY | MANAGEMENT | cerebral edema | PRACTICAL SCALE | BLOOD-FLOW | COMA DATA-BANK | ADULT | CLINICAL NEUROLOGY | brain injury | intracranial pressure | SEVERE HEAD-INJURY | HYPOTENSION | HYPERTENSION | INSULTS | cerebral perfusion pressure | Prospective Studies | Humans | Child, Preschool | Brain Injuries - complications | Infant | Male | Treatment Outcome | Cerebrovascular Circulation | Combined Modality Therapy | Intracranial Pressure - physiology | Likelihood Functions | Pilot Projects | Adolescent | Female | Child | Intracranial Hypertension - etiology | Intracranial Hypertension - physiopathology | Intracranial Hypertension - therapy
Journal Article
Pediatric Critical Care Medicine, ISSN 1529-7535, 05/2005, Volume 6, Issue 3, pp. 352 - 354
To present a case report of a patient with Noonan syndrome who developed life-threatening gastrointestinal bleeding shortly after cardiac surgery that was...
Critical care | Pediatrics | Recombinant factor VIIa | Noonan syndrome | Bleeding | Recombinant Proteins - therapeutic use | Factor VII - therapeutic use | Humans | Infant | Intensive Care Units, Pediatric | Male | Cardiac Surgical Procedures - adverse effects | Postoperative Hemorrhage - drug therapy | Noonan Syndrome - complications | Noonan Syndrome - surgery | Gastrointestinal Hemorrhage - etiology | Hemostatics - therapeutic use | Gastrointestinal Hemorrhage - drug therapy | Factor VIIa
Critical care | Pediatrics | Recombinant factor VIIa | Noonan syndrome | Bleeding | Recombinant Proteins - therapeutic use | Factor VII - therapeutic use | Humans | Infant | Intensive Care Units, Pediatric | Male | Cardiac Surgical Procedures - adverse effects | Postoperative Hemorrhage - drug therapy | Noonan Syndrome - complications | Noonan Syndrome - surgery | Gastrointestinal Hemorrhage - etiology | Hemostatics - therapeutic use | Gastrointestinal Hemorrhage - drug therapy | Factor VIIa
Journal Article
Journal of Neurosurgery: Pediatrics, ISSN 1933-0707, 05/2004, Volume 100, Issue 5, pp. 454 - 459
Journal Article
Pediatric Critical Care Medicine, ISSN 1529-7535, 2006, Volume 7, Issue 3, pp. 252 - 254
Objective. To describe the effects of enteral naloxone used to treat opioid-induced constipation in pediatric intensive care patients. Design: Retrospective...
Critical care | Pediatrics | Side effects | Naloxone | Constipation | Opioids | constipation | ORAL NALOXONE | pediatrics | critical care | naloxone | side effects | opioids | CRITICAL CARE MEDICINE | Humans | Child, Preschool | Infant | Intensive Care Units, Pediatric | Male | Naloxone - therapeutic use | Chi-Square Distribution | Constipation - chemically induced | Analgesics, Opioid - adverse effects | Analysis of Variance | Narcotic Antagonists - therapeutic use | Analgesics, Opioid - administration & dosage | Adolescent | Female | Constipation - drug therapy | Retrospective Studies | Child
Critical care | Pediatrics | Side effects | Naloxone | Constipation | Opioids | constipation | ORAL NALOXONE | pediatrics | critical care | naloxone | side effects | opioids | CRITICAL CARE MEDICINE | Humans | Child, Preschool | Infant | Intensive Care Units, Pediatric | Male | Naloxone - therapeutic use | Chi-Square Distribution | Constipation - chemically induced | Analgesics, Opioid - adverse effects | Analysis of Variance | Narcotic Antagonists - therapeutic use | Analgesics, Opioid - administration & dosage | Adolescent | Female | Constipation - drug therapy | Retrospective Studies | Child
Journal Article
Southern Medical Journal, ISSN 0038-4348, 02/2005, Volume 98, Issue 2, pp. 253 - 256
The authors describe a case of fatal hypermagnesemia caused by an Epsom salt enema. A 7-year-old male presented with cardiac arrest and was found to have a...
Death | Children | Epsom salt enema | Toxicity | Asystole | Hypermagnesemia | toxicity | MEDICINE, GENERAL & INTERNAL | asystole | THERAPY | death | children | EXTREME HYPERMAGNESEMIA | hypermagnesemia | SULFATE ENEMA | MAGNESIUM-CONTAINING CATHARTICS | Hyperlysinemias - etiology | Magnesium Sulfate - adverse effects | Abdominal Pain - therapy | Enema - adverse effects | Humans | Fatal Outcome | Male | Magnesium Sulfate - therapeutic use | Child | Magnesium - blood | Heart Arrest - therapy | Magnesium sulfate | Care and treatment | Risk factors | Magnesium deficiency diseases
Death | Children | Epsom salt enema | Toxicity | Asystole | Hypermagnesemia | toxicity | MEDICINE, GENERAL & INTERNAL | asystole | THERAPY | death | children | EXTREME HYPERMAGNESEMIA | hypermagnesemia | SULFATE ENEMA | MAGNESIUM-CONTAINING CATHARTICS | Hyperlysinemias - etiology | Magnesium Sulfate - adverse effects | Abdominal Pain - therapy | Enema - adverse effects | Humans | Fatal Outcome | Male | Magnesium Sulfate - therapeutic use | Child | Magnesium - blood | Heart Arrest - therapy | Magnesium sulfate | Care and treatment | Risk factors | Magnesium deficiency diseases
Journal Article